Clinical Edge Journal Scan

Nonsurgical periodontal treatment could improve disease activity in RA patients with periodontitis


 

Key clinical point: Nonsurgical periodontal treatment (NSPT) was associated with a significant reduction in disease activity score (DAS28), tender joint counts (TJC), swollen joint counts (SJC), visual analogical scale (VAS), and C-reactive protein (CRP) in patients with rheumatoid arthritis (RA) and periodontitis.

Major finding: NSPT significantly reduced DAS28 ( P less than .001), TJC ( P less than .001), SJC ( P = .008), VAS ( P = .02), and CRP ( P = .01) in patients with RA and periodontitis.

Study details: Data come from a meta-analysis of 9 studies that compared RA-related indicator changes between NSPT and no treatment groups.

Disclosures: The work was supported by the Natural Science Foundation of Tianjin, China, and the Science and Technology Foundation of Tianjin Health Commission, China. The authors declared no conflicts of interest.

Source: Sun J et al. Clin Oral Investig. 2021 Jan 29. doi: 10.1007/s00784-021-03807-w.

Recommended Reading

Methotrexate-associated hepatotoxicity risk differs between psoriasis, PsA, and RA patients
MDedge Rheumatology
ACR, AAD, AAO, RDS issue joint statement on safe use of hydroxychloroquine
MDedge Rheumatology
RA experts highlight key developments over the past year
MDedge Rheumatology
Filgotinib+MTX shows benefit in RA patients with inadequate response to MTX
MDedge Rheumatology
Anti-PAD3 positivity tied to higher disease activity and joint damage in RA
MDedge Rheumatology
Safety and efficacy of biosimilar CT-P17 and adalimumab in RA
MDedge Rheumatology
Modern treatment approach results in LDA and remission in pregnant patients with RA
MDedge Rheumatology
Impact of female hormonal exposure on risk of RA
MDedge Rheumatology
Younger RA patients at greater fracture risk even before age 50 years
MDedge Rheumatology
Anti-TNF responding RA: Tocilizumab bests rituximab in reducing disease activity
MDedge Rheumatology